Cyclacel pharmaceuticals to present at biotech showcase and participate in a corporate access event during the j.p. morgan healthcare conference in january 2023

Berkeley heights, n.j., dec. 15, 2022 (globe newswire) -- cyclacel pharmaceuticals, inc. (nasdaq: cycc, nasdaq: cyccp; "cyclacel" or the "company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, announced today that the company plans to present at the biotech showcase and host institutional investor and partnering meetings at this event and a corporate access event organized by lifesci partners. both in-person events are taking place january 9-11, 2023 in san francisco, california.
CYCC Ratings Summary
CYCC Quant Ranking